News
Immunetune in Top 25 of Health in Blue Tulip Awards 2020!
Immunetune is proud to have been selected as one of the Top 25 of the 2020 Blue Tulip Awards in the category Health! Click here for more information.
Neoantigen Summit Europe, April 7-9 in Amsterdam
CEO Gerben Zondag will present Immunetune's unique platform that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming Neoantigen Summit Europe, 7-9 April in Amsterdam. Update March 12. Unfortunately, but fully...
Immunetune featured in Biotech News & Life Science
Immunetune was featured in the December 2019 issue of Biotech News & Life Science, read the full article here (in Dutch only).
Neoantigen Summit Europe, April 7-9 in Amsterdam
CEO Gerben Zondag will present Immunetune's unique platform that enables time- and cost-efficient generation of personalized, DNA-based cancer vaccines at the upcoming Neoantigen Summit Europe, 7-9 April in Amsterdam. Update March 12. Unfortunately, but fully...
Immunetune featured in Biotech News & Life Science
Immunetune was featured in the December 2019 issue of Biotech News & Life Science, read the full article here (in Dutch only).
Biotech Wednesday: Joining forces to outsmart cancer
Immunetune will be attending Biotech Wednesday on November 20 in Utrecht, the Netherlands. Reach out to us through the networking app or contact us directly in case you'd like to learn more about Immunetune's approach to fight cancer. More information on this meeting...
Neoantigen Summit, 20-22 Nov in Boston
CSO Jeroen van Bergen will be presenting key highlights of Immunetune's preclinical proof-of-concept results at the Neoantigen summit in Boston, USA on November 20-22, 2019.